LLY vs ELV
By Alex · Tickerpine
Eli Lilly and Company vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | ELV |
|---|---|---|
| Price | $1,443.50 | $429.69 |
| Market cap | $1.29T | $92.84B |
| P/E ratio | 46.9 | 18.2 |
| ROE | 86.02% | 11.48% |
| Profit margin | 31.90% | 2.55% |
| Revenue growth | 38.60% | 1.40% |
| Dividend yield | 0.48% | 1.60% |
| Beta | 0.39 | 0.63 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs ELV in plain English
- LLY is the bigger company — about 13.8× the market cap of ELV.
- ELV is cheaper on earnings (P/E 18.2 vs 46.9).
- LLY earns a higher return on equity (86% vs 11%).
- LLY is growing revenue faster (39% vs 1%).
- ELV has the higher dividend yield (1.60% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.